121 related articles for article (PubMed ID: 8252717)
21. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
22. The effects of thyroid status on serum apolipoprotein A-I-containing lipoprotein particles.
Ozata M; Yildirimkaya M; Yilmaz K; Kutluay T; Corakci A; Beyhan Z; Gundogan MA
Horm Metab Res; 1998 Apr; 30(4):217-21. PubMed ID: 9623637
[TBL] [Abstract][Full Text] [Related]
23. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a).
Arem R; Escalante DA; Arem N; Morrisett JD; Patsch W
Metabolism; 1995 Dec; 44(12):1559-63. PubMed ID: 8786724
[TBL] [Abstract][Full Text] [Related]
24. Significant reduction of elevated serum lipoprotein(a) concentrations during levo-thyroxine-replacement therapy in a hypothyroid patient.
Murase T; Arimoto S; Okubo M; Morinaga S
J Clin Lipidol; 2012; 6(4):388-91. PubMed ID: 22836077
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
[TBL] [Abstract][Full Text] [Related]
26. Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism.
Oge A; Sozmen E; Karaoglu AO
Endocr Res; 2004 Aug; 30(3):481-9. PubMed ID: 15554363
[TBL] [Abstract][Full Text] [Related]
27. Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism.
Martínez-Triguero ML; Hernández-Mijares A; Nguyen TT; Muñoz ML; Peña H; Morillas C; Lorente D; Lluch I; Molina E
Mayo Clin Proc; 1998 Sep; 73(9):837-41. PubMed ID: 9737219
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein (a) in thyroid dysfunction before and after treatment.
Spandrio S; Sleiman I; Scalvini T; Salvi A; Di Stefano O; Pagliaini R; Balestrieri GP
Horm Metab Res; 1993 Nov; 25(11):586-9. PubMed ID: 8288162
[TBL] [Abstract][Full Text] [Related]
29. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats.
Staels B; Van Tol A; Chan L; Will H; Verhoeven G; Auwerx J
Endocrinology; 1990 Sep; 127(3):1144-52. PubMed ID: 2387252
[TBL] [Abstract][Full Text] [Related]
30. Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism.
Ma SG; Yang LX; Bai F; Xu W; Hong B
Eur J Intern Med; 2012 Sep; 23(6):e136-40. PubMed ID: 22863438
[TBL] [Abstract][Full Text] [Related]
31. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
[TBL] [Abstract][Full Text] [Related]
32. The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism.
Minarikova Z; Gaspar L; Kruzliak P; Celecová Z; Oravec S
Lipids Health Dis; 2014 Oct; 13():158. PubMed ID: 25300222
[TBL] [Abstract][Full Text] [Related]
33. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.
Ganotakis ES; Mandalaki K; Tampakaki M; Malliaraki N; Mandalakis E; Vrentzos G; Melissas J; Castanas E
Angiology; 2003; 54(5):569-76. PubMed ID: 14565632
[TBL] [Abstract][Full Text] [Related]
34. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
35. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
37. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy.
Arem R; Patsch W
Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095
[TBL] [Abstract][Full Text] [Related]
39. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status.
Lee WY; Suh JY; Rhee EJ; Park JS; Sung KC; Kim SW
Arch Med Res; 2004; 35(6):540-5. PubMed ID: 15631881
[TBL] [Abstract][Full Text] [Related]
40. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
